Lab-on-a-Printer developer Aspect Biosystems receives $1M investment from Genome BC Bioprinting
Canadian biotechnology company Aspect Biosystems has received a $1 million investment from Genome BC, a Vancouver-based non-profit dedicated to genomics innovation. The funding will go towards advancing and further commercializing Aspect Biosystems’ 3D bioprinting and tissue engineering platform.